- KuDOS Pharmaceuticals Ltd.
- Novacea Inc.
- Allos Therapeutics Inc.
- Pharmacyclics Inc.
- Cambridge Antibody Technology Group PLC
- Abbott Laboratories Inc.
- Genentech Inc.
- Micromet Inc.
- CTI BioPharma Corp.
- MedImmune LLC
- Johnson & Johnson
- Takeda Oncology
- Phytopharm PLC
- Alizyme PLC
- Astellas Pharma Inc.
- Takeda Pharmaceutical Co. Ltd.
- Novacea licenses cancer candidate from KuDOS
- Novacea gets $35mm in Series C round
- Micromet, Novuspharma team up to develop MT201 for cancer
- MedImmune helps Micromet develop MT103 for cancer; ends
- Millennium in giant cancer deal with Ortho Biotech
- Yamanouchi licenses Phytopharm's PYM50028; deal terminated
- Takeda gets Japanese rights to Alizyme's ATL-962 for obesity
Ask The Analyst
Ask the Analyst is free for subscribers. Submit your question and one of our analysts will be in touch.
Your question has been successfully sent to the email address below and we will get back as soon as possible. firstname.lastname@example.org.
All fields are required.
All set! This article has been sent to email@example.com.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
Please Note: Only individuals with an active subscription will be able to access the full article. All other readers will be directed to the abstract and would need to subscribe.